异常
发表于 2025-3-23 11:05:47
http://reply.papertrans.cn/32/3176/317535/317535_11.png
inhumane
发表于 2025-3-23 15:41:48
Management of Cardiogenic Shockextracorporeal membrane oxygenation (v-a ECMO). Despite widespread use of these medications and mechanical devices, there are limited data supporting their use. In this chapter we review the guidelines and existing evidence for the management of CS complicating acute MI.
滔滔不绝地讲
发表于 2025-3-23 18:10:22
https://doi.org/10.1057/9781137313416iated injuries should be considered when determining hemodynamic goals of resuscitation; however, existing recommendations (i.e. target blood pressure in head injury) are based off expert consensus in the absence of randomized control trials.
逢迎白雪
发表于 2025-3-23 23:05:40
http://reply.papertrans.cn/32/3176/317535/317535_14.png
利用
发表于 2025-3-24 04:00:23
Textbook 2020Latest editions, fellows, residents; allied health professionals and medical students who wish to expand their knowledge within critical care. The case study-based approach taken in the textbook makes this an idealresource for those preparing for board examinations..
宽容
发表于 2025-3-24 06:39:17
http://reply.papertrans.cn/32/3176/317535/317535_16.png
脱离
发表于 2025-3-24 14:01:54
,The Western Hostage Saga, 1984–92,t addresses all components of PCAS is critical to achieve optimal patient outcome. In addition, a reliable multimodal strategy to prognosticate neurologic outcome in comatose patients is essential to prevent premature cessation of care and enable appropriate resource utilization (Callaway et al., Ci
ALIAS
发表于 2025-3-24 18:45:38
http://reply.papertrans.cn/32/3176/317535/317535_18.png
Carminative
发表于 2025-3-24 20:58:15
http://reply.papertrans.cn/32/3176/317535/317535_19.png
打火石
发表于 2025-3-25 01:51:02
Islamic Law and Transnational Diplomatic Lawor in a competitive manner. At therapeutic doses, this is intended to decrease hypertension, tachycardias, myocardial oxygen demand and myocardial remodeling (Waagstein et al., Br Heart J 37:1022–1036, 1975). There are a wide variety of beta-blockers, some of which are selective antagonists of eithe